e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognostic evaluation in Chinese patients with idiopathic pulmonary fibrosis
M. T. Cai, H. Dai, C. J. Ban, S. Zhang, Q. Ye, C. Wang (Beijing, China)
Source:
Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Session:
Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Session type:
Thematic Poster Session
Number:
3479
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. T. Cai, H. Dai, C. J. Ban, S. Zhang, Q. Ye, C. Wang (Beijing, China). Prognostic evaluation in Chinese patients with idiopathic pulmonary fibrosis. Eur Respir J 2008; 32: Suppl. 52, 3479
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Prognostic evaluation in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Prognostic factors of idiopathic pulmonary fibrosis diagnosed by surgical lung biopsy
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
Prognostic factors affecting survival of idiopathic pulmonary fibrosis in Korean population
Source: Eur Respir J 2007; 30: Suppl. 51, 578s
Year: 2007
Clinical significance of autoantibody screening in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Clinical course of idiopathic pulmonary fibrosis (IPF): Prediction and outcome
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Comparison of clinical characteristics and prognosis in patients with idiopathic pulmonary upper lobe predominant pulmonary fibrosis and idiopathic pulmonary fibrosis
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Dyspnoea: a prognostic marker for idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 37: 476
Year: 2011
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015
Assessment of nutritional status in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016
Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis
Source: Eur Respir J, 50 (1) 1700379; 10.1183/13993003.00379-2017
Year: 2017
Registry of idiopathic pulmonary fibrosis patients
Source: International Congress 2016 – Russia Session
Year: 2016
Clinical features of patients with idiopathic pulmonary upper lobe-dominant fibrosis
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
Source: ERJ Open Res, 5 (3) 00170-2018; 10.1183/23120541.00170-2018
Year: 2019
Clinical characteristics and survival in patients with idiopathic pulmonary fibrosis with and without associated emphysema
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Clinical features and predictive factors for acute exacerbation of idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis
Year: 2007
Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis
Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept